Search

Show 37690 results
Displaying 1211–1220 of 37690 results.
  • Health Outcomes
    Aaron Mitchell

    … Job Title Assistant Attending Dr. Mitchell is an oncologist and health services researcher. He completed his clinical training at Duke University Hospital (Residency, internal medicine) and at University of North Carolina at Chapel Hill (Fellowship, medical oncology). He received an MPH in epidemiology

  • How to Apply

    Learn how to apply for a Functional Genomics Initiative grant.

    … Please check InfoReady for any current Funding Opportunities. You must also fill out this  disclosure form disclosure form .

  • Video
    Insomnia in Cancer Patients and Survivors

    Sleep expert Amy Lowery notes that insomnia is a common problem for cancer patients and survivors.

    … Insomnia is the most common sleep disorder in cancer patients and survivors, says Memorial Sloan Kettering sleep expert Amy Lowery. Chronic insomnia can lead to depression, anxiety, pain, fatigue, memory and cognitive impairment, and other health problems. To prevent insomnia, Dr. Lowery recommends maintaining

  • Clinical Trial
    A Phase 3 Study Comparing Elranatamab Alone, Elranatamab with Daratumumab, and Daratumumab/Pomalidomide/Dexamethasone in People with Multiple Myeloma

    … Full Title An Open-Label, 3-Arm, Multicenter, Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Elranatamab (PF-06863135) Monotherapy and Elranatamab Plus Daratumumab Versus Daratumumab Plus Pomalidomide plus Dexamethasone in Participants with Relapsed/Refractory Multiple Myeloma Who Have

  • The Jason Lewis Lab
    Candace Parker

    … Job Title Research Scholar Start Year 2023

  • Sham Mailankody
    Myeloma Specialist
    Sham Mailankody

    I am a medical oncologist and hematologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center, I am focused on identifying optimal treatment strategies for people with these disorders. I am interested in the molecular pathways underlying progression of plasma cell disorders and the development of targeted strategies aiming to delay, prevent, and cure full-blown disease. I also have an interest in health policy as it relates to oncologic drug approvals and the cost of cancer care.

    … Myeloma Specialist & Cellular Therapist Job Title Clinical Director, Cellular Therapy Service; Research Director, Myeloma Service I am a medical oncologist specializing in the care of people with multiple myeloma and related plasma cell disorders . With my colleagues at Memorial Sloan Kettering Cancer

  • Sham Mailankody
    Myeloma Specialist
    Sham Mailankody

    Soy oncólogo médico y hematólogo especializado en la atención de personas con mieloma múltiple y trastornos relacionados con el plasma celular. Junto a mis colegas del Memorial Sloan Kettering Cancer Center, nos centramos en identificar las mejores estrategias de tratamiento para personas con este tipo de enfermedades. Estoy interesado en los mecanismos moleculares que marcan el avance del trastorno de las células plasmáticas y el desarrollo de estrategias dirigidas que buscan retrasar, prevenir y curar la enfermedad completamente. También tengo interés en la política sanitaria, ya que se relaciona con las aprobaciones de fármacos oncológicos y el costo del cuidado del cáncer.

    … Myeloma Specialist & Cellular Therapist Job Title Director clínico del Servicio de Terapia Celular; Director de Investigación del Servicio de Mieloma Soy oncólogo médico y hematólogo especializado en la atención de personas con mieloma múltiple y trastornos relacionados con el plasma celular . Junto

  • News
    Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team”

    Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

    … Wednesday, December 14, 2011 Summary Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. Stand Up To Cancer (SU2C) has appointed five Memorial Sloan Kettering scientists to its new “Dream

  • The Richard White Lab
    Eleanor Johns

    … Job Title Graduate Student

  • The Joseph Deasy Lab
    At Work: Physicist Joseph Deasy

    Physicist Joseph O. Deasy, Chair of the Department of Medical Physics and an expert in radiation therapy, uses physics to contribute to the fight against cancer.

    … Physicist Joseph O. Deasy joined Memorial Sloan Kettering Cancer Center in 2010 as Chair of the Department of Medical Physics and incumbent of the Enid A. Haupt Chair in Medical Physics. An expert in radiation therapy, Dr. Deasy is dedicated to developing new ways to optimize and plan treatments on a